Scoping review maps clinical oral and periodontal outcomes in humans receiving GLP-1 receptor agonists, suggesting important implications for oral health.
To map the extent, range, and nature of the published evidence on clinical oral and periodontal outcomes in humans receiving GLP-1 receptor agonists.
No takes yet. Share an insight, caveat, or question.
Hayat et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: